Valuation: Vineet Laboratories Limited

Market Cap 558M 5.84M 5.13M 4.77M 4.39M 8.23M 8.37M 56.64M 22.17M 277M 21.93M 21.46M 956M P/E 2024
43.6x
P/E 2025 -1.42x
Enterprise Value 956M 10M 8.78M 8.17M 7.52M 14.09M 14.33M 96.97M 37.96M 474M 37.55M 36.74M 1.64B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
63.66%
Yield 2024 *
-
Yield 2025 -
07-21 Vineet Laboratories Limited Announces Cessation of Gaddam Venkata Ramana to Hold the Office of Managing Director, Effective July 21, 2026 CI
05-29 Vineet Laboratories Limited Announces Resignation of Ramesh Kumar Bandari from Company Secretary and Compliance Officer and Ceases to Be Key Managerial Personnel, Effective May 29, 2026 CI
02-14 Vineet Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02-07 Vineet Laboratories Limited Approves Appointment of Jasmin Kunal Tailor as Independent Director CI
12-17 Vineet Laboratories says rights issue price set at 30 rupees per share RE
11-27 Vineet Laboratories Gets Board Nod to Raise Up to INR300 Million via Rights Issue MT
11-27 Vineet Laboratories to raise funds up to 300 million rupees via rights issue RE
11-24 Vineet Laboratories to consider rights issue RE
11-08 Vineet Laboratories Limited Announces Resignation of Hari Priya Yerukalapudi as Independent Director, Effective November 08, 2025 CI
16/09/25 Vineet Laboratories Limited Approves the Appointment of Premananda Reddy Vennapusa as Non-Executive Director, Effective from September 15, 2025 CI
22/07/25 Vineet Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
12/05/25 Vineet Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/11/24 Vineet Laboratories Limited Announces Resignation of Bhaskara Reddy Karna as Independent Director CI
1 day+0.75%
1 week+3.13%
Current month+15.97%
1 month+15.32%
3 months+7.60%
6 months+17.29%
Current year+6.61%
1 week 35.65
Extreme 35.65
40
1 month 31.5
Extreme 31.5
40
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
114.9
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Director of Finance/CFO 76 01/01/2021
Human Resources Officer - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 56 10/11/2016
Director/Board Member 76 10/11/2016
Chairman 73 16/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.75%+3.13%+28.10%-22.36% 7.82M
+0.43%+5.27%+60.46%+169.33% 1,089B
+0.65%+4.94%+59.58%+60.13% 643B
+1.53%+5.44%+39.67%+78.55% 465B
-1.69%+8.81%+39.38%+33.67% 359B
-0.51%+3.51%+36.97%+42.46% 303B
+1.38%+3.28%+17.57%+17.27% 267B
+0.79%+5.81%-2.55%-38.10% 226B
-0.31%+7.24%+29.32%+67.66% 212B
-0.15%+2.94%+17.46%+76.21% 167B
Average +0.30%+4.80%+32.60%+48.48% 373.11B
Weighted average by Cap. +0.36%+5.14%+43.20%+82.42%

Financials

2024 2025
Net sales 1.51K 15.8 13.87 12.91 11.88 22.27 22.65 153.2 59.97 748.68 59.32 58.04 2.59K 769.53 8.05 7.07 6.58 6.05 11.35 11.54 78.09 30.57 381.64 30.24 29.59 1.32K
Net income 10.27M 108K 94.35K 87.86K 80.81K 151K 154K 1.04M 408K 5.09M 404K 395K 17.6M -202M -2.11M -1.85M -1.73M -1.59M -2.98M -3.03M -20.49M -8.02M -100M -7.93M -7.76M -346M
Net Debt 441M 4.61M 4.05M 3.77M 3.47M 6.5M 6.61M 44.73M 17.51M 219M 17.32M 16.94M 755M 397M 4.16M 3.65M 3.4M 3.13M 5.86M 5.96M 40.33M 15.79M 197M 15.62M 15.28M 681M
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
29/07/26 39.21 +0.75% 74,565
28/07/26 ₹38.92 +0.13% 23,066
27/07/26 ₹38.87 +0.91% 49,004
24/07/26 ₹38.52 +2.99% 73,138
23/07/26 ₹37.40 +0.19% 50,064
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock